title: Human chorionic gonadotropin: Different glycoforms and biological activity depending on its source of production.
abstract: Human chorionic gonadotropin (hCG) is the first hormonal message from the placenta to the mother. It is detectable in maternal blood two days after implantation and behaves like a super LH agonist stimulating progesterone secretion by the corpus luteum. In addition to maintaining the production of progesterone until the placenta itself produces it, hCG also has a role in myometrial quiescence and local immune tolerance. Specific to humans, hCG is a complex glycoprotein composed of two highly glycosylated subunits. The α-subunit is identical to the pituitary gonadotropin hormones (LH, FSH, TSH), contains two N-glycosylation sites, and is encoded by a single gene (CGA). By contrast, the β-subunits are distinct for each hormones and confer both receptor and biological specificity, although LH and hCG bind to the same receptor (LH/CG-R). The hCG ß-subunit is encoded by a cluster of genes (CGB) and contains two sites of N-glycosylation and four sites of O-glycosylation. The hCG glycosylation state varies with the stage of pregnancy, its source of production and in the pathology. It is well established that hCG is mainly secreted into maternal blood, where it peaks at 8-10weeks of gestation (WG), by the syncytiotrophoblast (ST), which represents the endocrine tissue of the human placenta. The invasive extravillous trophoblast (iEVT) also secretes hCG, and in particular hyperglycosylated forms of hCG (hCG-H) also produced by choriocarcinoma cells. In maternal blood, hCG-H is elevated during early first trimester corresponding to the trophoblastic cell invasion process and then decreases. In addition to its endocrine role, hCG has autocrine and paracrine roles. It promotes formation of the ST and angiogenesis through LH/CG-R but has no effect on trophoblast invasion in vitro. By contrast, hCG-H stimulates trophoblast invasion and angiogenesis by interacting with the TGFß receptor in a LH/CG-R independent signalling pathway. hCG is largely used in antenatal screening and hCG-H might represent a serum marker of implantation and early trophoblast invasion. In conclusion, hCG is the major pregnancy glycoprotein hormone, whose maternal concentration and glycan structure change all along pregnancy. Depending on its source of production, glycoforms of hCG display different biological activities and functions that are essential for pregnancy outcome.
authors.affiliation: Inserm, U1139, PremUp Foundation, université Paris Descartes, UMR-S1139, Sorbonne Paris Cité, DHU "Risk & pregnancy", 75006 Paris, France. Electronic address: thierry.fournier@parisdescartes.fr.
authors.forename: Thierry
authors.initials: T
authors.lastname: Fournier
mesh_terms: D006063:Chorionic Gonadotropin / Q000737:chemistry* / Q000378:metabolism / Q000502:physiology*; D005260:Female; D006801:Humans; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D020033:Protein Isoforms; D013329:Structure-Activity Relationship; D014327:Trophoblasts / Q000502:physiology
chemical_list: D006063:Chorionic Gonadotropin; D020033:Protein Isoforms; C024889:glycosylated HCG
keywords: Extravillous trophoblast; Glycoproteins; Glycoprotéine; Glycosylation; Invasion; Recepteur; Receptors; Structure-fonction; Structure-function; Syncytiotrophoblast; Syncytiotrophoblaste; Trophoblaste extravilleux